- Home
- NUWE
NUWE
Nuwellis Inc.
as 04-24-2025 4:00pm EST
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | EDEN PRAIRIE |
| Market Cap: | 3.9M | IPO Year: | N/A |
| Target Price: | $17.00 | AVG Volume (30 days): | 61.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.75 - $14.00 | Next Earning Date: | 05-06-2025 |
| Revenue: | $8,740,000 | Revenue Growth: | -1.40% |
| Revenue Growth (this year): | 22.96% | Revenue Growth (next year): | 29.97% |
Latest Nuwellis Inc. News
NUWE Breaking Stock News: Dive into NUWE Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision
GlobeNewswire
3 days ago
Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025
GuruFocus.com
4 days ago
Nuwellis Inc (NUWE) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges with ...
GlobeNewswire
a month ago
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
2 months ago
Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO
GlobeNewswire
2 months ago
JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis
GlobeNewswire
2 months ago
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
GlobeNewswire
3 months ago
Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® Therapy
Compare NUWE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NUWE Nuwellis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.